VEEV

Veeva Systems Inc Class A

VEEV, USA

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud consisting of Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; and Veeva RIM that provides regulatory information management capabilities; as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.

https://www.veeva.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
VEEV
stock
VEEV

Veeva Systems Appoints New Principal Accounting Officer TipRanks

Read more →
VEEV
stock
VEEV

Noteworthy Thursday Option Activity: VEEV, COP, JBLU Nasdaq

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-10-31)

Rating:

BUY

Target Price:

$315.171

Analyst Picks

Strong Buy

12

Buy

7

Hold

11

Sell

1

Strong Sell

1

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-10-31)

Health Score

Price to Earnings Ratio (P/E)

-

Very Low

46.77

Low ≥ 50

High ≤ 10

Price to Book Ratio (P/B)

-

Very High

5.33

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

3.35 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

2.92 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very High

22.99 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very High

0.15

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 65.52% of the total shares of Veeva Systems Inc Class A

1.

Vanguard Group Inc

(9.134%)

since

2025/06/30

2.

BlackRock Inc

(6.6394%)

since

2025/06/30

3.

FMR Inc

(3.4848%)

since

2025/06/30

4.

AllianceBernstein L.P.

(3.481%)

since

2025/06/30

5.

Vanguard Total Stock Mkt Idx Inv

(2.8091%)

since

2025/07/31

7.

Principal Financial Group Inc

(2.1097%)

since

2025/06/30

8.

State Street Corp

(2.091%)

since

2025/06/30

9.

JPMorgan Chase & Co

(2.0233%)

since

2025/06/30

10.

Vanguard Mid Cap Index Institutional

(1.9929%)

since

2025/07/31

11.

Geode Capital Management, LLC

(1.8868%)

since

2025/06/30

12.

Massachusetts Financial Services Company

(1.7417%)

since

2025/06/30

13.

Tiger Technology Management LLC

(1.4767%)

since

2025/06/30

14.

Principal MidCap R5

(1.454%)

since

2025/07/31

15.

AllianceBernstein US L/C Growth Eqty MF

(1.4303%)

since

2025/07/31

16.

Principal Aligned MidCap Equity

(1.4148%)

since

2025/06/30

17.

T. Rowe Price US Mid-Cap Growth Equity

(1.2812%)

since

2025/06/30

18.

Linonia Partnership LP

(1.2636%)

since

2025/06/30

19.

Nuveen, LLC

(1.2202%)

since

2025/06/30

20.

UBS Asset Mgmt Americas Inc

(1.1656%)

since

2025/06/30

21.

T. Rowe Price Mid-Cap Growth

(1.1327%)

since

2025/07/31

22.

AQR Capital Management LLC

(1.1214%)

since

2025/06/30

23.

T. Rowe Price Associates, Inc.

(1.1065%)

since

2025/06/30

24.

Vanguard Growth Index Investor

(1.0169%)

since

2025/07/31

25.

Vanguard Institutional Extnd Mkt Idx Tr

(0.9828%)

since

2025/07/31

26.

Stockbridge Partners LLC

(0.9525%)

since

2025/06/30

27.

AB Large Cap Growth A

(0.916%)

since

2025/07/31

28.

Wellington Management Company LLP

(0.8837%)

since

2025/06/30

29.

Franklin Resources Inc

(0.8457%)

since

2025/06/30

30.

NORGES BANK

(0.8141%)

since

2025/06/30

31.

Vanguard Mid-Cap Growth ETF

(0.7462%)

since

2025/07/31

32.

US Small-Cap Growth II Equity Comp

(0.5088%)

since

2025/06/30

33.

MFS Growth Equity

(0.5085%)

since

2025/06/30

34.

Fidelity Extended Market Index

(0.4926%)

since

2025/07/31

35.

MFS Mid Cap Growth Equity

(0.4756%)

since

2025/06/30

36.

iShares Russell Mid-Cap Growth ETF

(0.4722%)

since

2025/08/31

37.

MFS Mid Cap Growth A

(0.4632%)

since

2025/07/31

38.

Fidelity Select Medical Tech and Devcs

(0.4319%)

since

2025/07/31

39.

JPM US Mid Cap Growth-Composite

(0.4236%)

since

2025/06/30

40.

JPMorgan Mid Cap Growth I

(0.4223%)

since

2025/07/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2026-01-31

EPS Estimate

1.93

Latest Release

Date

2025-10-31

EPS Actual

2.04

EPS Estimate

1.95

EPS Difference

0.09

Surprise Percent

4.6154%

Investing Fit Scorecard

(Last Updated 2025-10-31)

Deep Value
Potential Value Candidate(5.5)
Defensive
Highly Defensive(8.5)
Dividend
Weak Dividend Profile(3)
Economic Moat
Wide Moat Company(8.8)
GARP
Fair GARP(5)
Growth
Moderate Growth(4)
Momentum
Moderate Momentum(4)
Net Net
Possible Net-Net(4)
Quality
High Quality(7.5)
Value
Fair Value(4)

Income Statement

(Last Updated 2025-10-31)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-10-31)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-10-31)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.